-
1دورية أكاديمية
المؤلفون: Iida, S, Ishikawa, T, Min, CK, Kim, K, Yeh, SP, Usmani, SZ, Mateos, MV, Nahi, H, Heuck, C, Qin, X, Parasrampuria, DA, Gries, KS, Qi, M, Bahlis, N, Ito, S
المصدر: Annals of hematology. 101(100):1065-1077
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المؤلفون: Perrot, A, Facon, T, Plesner, T, Usmani, SZ, Kumar, S, Bahlis, NJ, Hulin, C, Orlowski, RZ, Nahi, H, Mollee, P, Ramasamy, K, Roussel, M, Jaccard, A, Delforge, M, Karlin, L, Arnulf, B, Chari, A, He, JM, Ho, KF, Van Rampelbergh, R, Uhlar, CM, Wang, JP, Kobos, R, Gries, KS, Fastenau, J, Weisel, K
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(3):227
مصطلحات موضوعية: Medicin och hälsovetenskap
-
3دورية أكاديمية
المؤلفون: Usmani, SZ, Mateos, MV, Hungria, V, Iida, S, Bahlis, NJ, Nahi, H, Magen, H, Cavo, M, Hulin, C, White, D, De Stefano, V, Fastenau, J, Slavcev, M, Heuck, C, Qin, X, Pei, HL, Masterson, T, Lantz, K, Gries, KS
المصدر: Journal of cancer research and clinical oncology. 147(3):619-631
مصطلحات موضوعية: Medicin och hälsovetenskap
-
4مؤتمر
المؤلفون: Perrot, A, Facon, T, Plesner, T, Usmani, S, Kumar, SK, Bahlis, NJ, Hulin, C, Orlowski, RZ, Nahi, H, Mollee, P, Ramasamy, K, Roussel, M, Jaccard, A, Delforge, M, Karlin, L, Arnulf, B, Chari, A, Pei, H, Gupta, N, Kaila, S, Matt, K, Gries, KS, Carson, R, Borgsten, F, Weisel, K
المصدر: BLOOD. 140:1142-1145
مصطلحات موضوعية: Medicin och hälsovetenskap
-
5دورية أكاديمية
المؤلفون: Mateos, MV, Cohen, AD, Cohen, YC, Agha, M, San-Miguel, J., Richard, S, van de Donk, NWCJ, Champlain A, De, Katz, EG, Iaconangelo, C, Braganca KC, De, Schecter, JM, Varsos, H, Corsale, C, Deraedt, W, Koneru, M, Filho O, Costa, Akram, M, Gries, KS
المصدر: In Value in Health June 2024 27(6) Supplement:S320-S320
-
6
المؤلفون: Plesner, T, Dimopoulos, MA, Oriol, A, San-Miguel, J, Bahlis, NJ, Rabin, N, Suzuki, K, Yoon, SS, Ben-Yehuda, D, Cook, G, Goldschmidt, H, Grosicki, S, Qin, X, Fastenau, J, Garvin, W, Carson, R, Renaud, T, Gries, KS
المصدر: British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instnameمصطلحات موضوعية: relapsed, refractory multiple myeloma, reported outcomes, POLLUX, daratumumab, health‐, related quality of life, patient‐
-
7
المؤلفون: Roussel, M, Moreau, P, Hebraud, B, Laribi, K, Jaccard, A, Dib, M, Slama, B, Dorvaux, V, Royer, B, Frenzel, L, Zweegman, S, Klein, SK, Broijl, A., Jie, KS, Wang, J, Vanquickelberghe, V, Boer, C, Kampfenkel, T, Gries, KS, Fastenau, J, Sonneveld, Pieter
المساهمون: Hematology
المصدر: The Lancet Haematology, 7(12), E874-E883. Lancet Publishing Group
-
8مؤتمر
المؤلفون: Perrot, A, Facon, T, Kumar, S, Plesner, T, Orlowski, RZ, Moreau, P, Bahlis, NJ, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, ME, Venner, CP, Weisel, K, Mace, JR, Raje, NS, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Liu, K, Fastenau, J, Gries, KS, Ho, KF, Mistry, P, Tromp, B, Delioukina, M, Vermeulen, J, Usmani, SZ
المصدر: BLOOD. 138
مصطلحات موضوعية: Medicin och hälsovetenskap
-
9مؤتمر
المؤلفون: Perrot, A, Facon, T, Kumar, S, Plesner, T, Orlowski, RZ, Moreau, P, Bahlis, NJ, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, ME, Venner, CP, Weisel, K, Mace, JR, Raje, NS, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Liu, K, Fastenau, J, Gries, KS, Ho, KF, Mistry, P, Tromp, B, Delioukina, M, Vermeulen, J, Usmani, SZ
المصدر: BLOOD. 138
مصطلحات موضوعية: Medicin och hälsovetenskap
-
10دورية أكاديمية
المؤلفون: Silbermann R; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Laubach J; Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA., Kaufman JL; Department of Mematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Sborov DW; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA., Reeves B; Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA., Rodriguez C; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA., Chari A; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA., Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Anderson LD Jr; Division of Hematology/Oncology, Simmons Comprehensive Cancer Center, UT Texas Southwestern Medical Center, Dallas, Texas, USA., Nathwani N; Division of Myeloma, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Shah N; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Holstein SA; Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Costello C; Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, California, USA., Jakubowiak A; Medicine- Hematology and Oncology, University of Chicago, Chicago, Illinois, USA., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Cowan AJ; Department of Medicine, University of Washington, Seattle, Washington, USA., Gries KS; Janssen Research & Development, Raritan, New Jersey, USA., Pei H; Janssen Research & Development, LLC, Titusville, New Jersey, USA., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Patel S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Voorhees PM; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest University School of Medicine, Charlotte, North Carolina, USA., Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Richardson PG; Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.
المصدر: American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1257-1268. Date of Electronic Publication: 2024 Apr 15.
نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study; Randomized Controlled Trial
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Quality of Life* , Bortezomib*/administration & dosage , Bortezomib*/therapeutic use , Dexamethasone*/administration & dosage , Dexamethasone*/therapeutic use , Lenalidomide*/administration & dosage , Lenalidomide*/therapeutic use , Patient Reported Outcome Measures* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult